Altimmune (ALT) Common Equity (2010 - 2026)
Altimmune (ALT) posted Common Equity of $474.21 million for Q2 2026, up 193.9% from $161.37 million a year earlier and up 67.0% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Altimmune's Common Equity came in at $224.89 million, up 82.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- In prior years, Altimmune's Common Equity was $123.51 million in FY2024 (-36.4%), $194.1 million in FY2023 (+4.8%), $185.29 million in FY2022 (-7.0%) and $199.14 million in FY2021 (-11.8%).
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2010.
- On a year-over-year basis, Common Equity has increased in each of the last five quarters, with growth averaging 44.4% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 193.9%; the weakest was Q4 2024, with a decline of 36.4%.
- According to Business Quant data, Common Equity for the three prior quarters was $283.99 million (Q1 2026), $224.89 million (Q4 2025) and $185.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | 474.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 474.21 Mn |
| Mar 31, 2026 | 283.99 Mn |
| Dec 31, 2025 | 224.89 Mn |
| Sep 30, 2025 | 185.60 Mn |
| Jun 30, 2025 | 161.37 Mn |
| Mar 31, 2025 | 142.16 Mn |
| Dec 31, 2024 | 123.51 Mn |
| Sep 30, 2024 | 133.38 Mn |
| Jun 30, 2024 | 152.53 Mn |
| Mar 31, 2024 | 172.94 Mn |
| Dec 31, 2023 | 194.10 Mn |
| Sep 30, 2023 | 150.40 Mn |
| Jun 30, 2023 | 167.71 Mn |
| Mar 31, 2023 | 167.73 Mn |
| Dec 31, 2022 | 185.29 Mn |
| Sep 30, 2022 | 205.03 Mn |
| Jun 30, 2022 | 194.54 Mn |
| Mar 31, 2022 | 184.87 Mn |
| Dec 31, 2021 | 199.14 Mn |
| Sep 30, 2021 | 209.26 Mn |
API Access
Altimmune Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();